Coexpression of Ki-67 and PCNA in precancer lesions in chronic diffuse lung diseases (CDLD) as a predictor of their malignant potential

E. A. Kogan, N. B. Paramonova, V. P. Seredin (Moscow, Russia)

Source: Annual Congress 2001 - Early lung cancer
Session: Early lung cancer
Session type: Oral Presentation
Number: 246
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. A. Kogan, N. B. Paramonova, V. P. Seredin (Moscow, Russia). Coexpression of Ki-67 and PCNA in precancer lesions in chronic diffuse lung diseases (CDLD) as a predictor of their malignant potential. Eur Respir J 2001; 16: Suppl. 31, 246

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The expression of Ki-67 in preneoplastic and early neoplastic bronchial lesions
Source: Eur Respir J 2001; 18: Suppl. 33, 18s
Year: 2001

The expression of Ki-67 in preneoplastic and early neoplastic bronchial lesions
Source: Eur Respir J 2002; 20: Suppl. 38, 229s
Year: 2002

Lung cancer: immunopathology
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=48
Year: 2001

The differential diagnosis of pulmonary pre-invasive lesions
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=37
Year: 2007

Early lung carcinogenesis: MDM2 expression in bronchial preneoplastic lesions and its correlation with p53
Source: Eur Respir J 2005; 26: Suppl. 49, 458s
Year: 2005

Angiogenesis in preinvasive, early invasive bronchial lesions and micropapillomatosis and correlation with EGF-R expression
Source: Annual Congress 2006 - Lung cancer biology and chemosensitivity
Year: 2006


Clinical prognostic indicators of high-grade pre-invasive bronchial lesions
Source: Eur Respir J 2004; 24: 24-29
Year: 2004



Depiction of malignancy in patients with diffuse interstitial lung disease (DILD) presenting with nodular opacities
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008


The clinical effect and expression of alpha-methylacyl-CoA racemace (AMACR) in the differential diagnosis of malign mesothelioma and adenocarcinoma of lung
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012


Correlation of P53 and CerbB-2 expression in the diagnostic biopsies and the corresponding resected tumors in non small cell lung caner
Source: Eur Respir J 2004; 24: Suppl. 48, 43s
Year: 2004

Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease.
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Year: 2021



Role of transcription factors ASCL1 and HES1 expression in diffuse idiopathic neuroendocrine cell hyperplasia (DIPNECH) and pulmonary carcinoids
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013

Different prevalence of positivity for human mammaglobin (hMAM) transcipts in the pleural fluid of patients with malignant vs. non malignant pleural disease
Source: Eur Respir J 2006; 28: Suppl. 50, 580s
Year: 2006

The benefit of surgical lung biopsy in diagnosis and prognosis of diffuse infiltrative lung disease
Source: Annual Congress 2007 - Staging, diagnostic procedures and complex situations in thoracic surgery
Year: 2007


Her-2/neu expression in advanced non small cell lung carcinomas
Source: Eur Respir J 2004; 24: Suppl. 48, 77s
Year: 2004

Immunophenotypic profiles of lung carcinomas associated with idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008

Combined expression of p53, Bcl-2 and p21WAF-1 proteins in endobronchial biopsies may be associated with lung cancer prognosis
Source: Eur Respir J 2001; 18: Suppl. 33, 230s
Year: 2001

The expression of Ki-67, a marker of proliferative activity, in resected nonsmall cell lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 478s
Year: 2001

Predicting activity of EGFR (epidermal growth factor receptor) inhibitors in diffuse bronchiolo-alveolar carcinoma or so-called pneumonic adenocarcinoma
Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma
Year: 2006


The role of P53 tumor suppressor gene mutations in early diagnosis of lung cancer among patients with solitary pulmonary nodule
Source: Annual Congress 2009 - Pathogenesis of lung cancer
Year: 2009